Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Schistosoma mansoni Worm Infection Regulates the Intestinal Microbiota and Susceptibility to Colitis.

Floudas A, Aviello G, Schwartz C, Jeffery IB, O'Toole PW, Fallon PG.

Infect Immun. 2019 Jul 23;87(8). pii: e00275-19. doi: 10.1128/IAI.00275-19. Print 2019 Aug.

PMID:
31138616
2.

Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β.

Schwartz C, Moran T, Saunders SP, Kaszlikowska A, Floudas A, Bom J, Nunez G, Iwakura Y, O'Neill L, Irvine AD, McKenzie ANJ, Ogg G, Walsh PT, Demengeot J, Fallon PG.

Allergy. 2019 Apr 2. doi: 10.1111/all.13801. [Epub ahead of print]

PMID:
30937919
3.

Composition of the Schistosoma mansoni worm secretome: Identification of immune modulatory Cyclophilin A.

Floudas A, Cluxton CD, Fahel J, Khan AR, Saunders SP, Amu S, Alcami A, Fallon PG.

PLoS Negl Trop Dis. 2017 Oct 26;11(10):e0006012. doi: 10.1371/journal.pntd.0006012. eCollection 2017 Oct.

4.

ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control.

Schwartz C, Khan AR, Floudas A, Saunders SP, Hams E, Rodewald HR, McKenzie ANJ, Fallon PG.

J Exp Med. 2017 Sep 4;214(9):2507-2521. doi: 10.1084/jem.20170051. Epub 2017 Jul 26.

5.

IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.

Floudas A, Saunders SP, Moran T, Schwartz C, Hams E, Fitzgerald DC, Johnston JA, Ogg GS, McKenzie AN, Walsh PT, Fallon PG.

J Immunol. 2017 Jul 15;199(2):707-717. doi: 10.4049/jimmunol.1602185. Epub 2017 Jun 14.

6.

New Insights into IL-10 Dependent and IL-10 Independent Mechanisms of Regulatory B Cell Immune Suppression.

Floudas A, Amu S, Fallon PG.

J Clin Immunol. 2016 May;36 Suppl 1:25-33. doi: 10.1007/s10875-016-0263-8. Epub 2016 Mar 23. Review.

PMID:
27008462
7.

Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity.

Saunders SP, Moran T, Floudas A, Wurlod F, Kaszlikowska A, Salimi M, Quinn EM, Oliphant CJ, Núñez G, McManus R, Hams E, Irvine AD, McKenzie AN, Ogg GS, Fallon PG.

J Allergy Clin Immunol. 2016 Feb;137(2):482-91. doi: 10.1016/j.jaci.2015.06.045. Epub 2015 Aug 20.

8.

RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial.

Jopson L, Newton JL, Palmer J, Floudas A, Isaacs J, Qian J, Wilkinson J, Trenell M, Blamire A, Howel D, Jones DE.

BMJ Open. 2015 Aug 20;5(8):e007985. doi: 10.1136/bmjopen-2015-007985.

9.

PD-L1hi B cells are critical regulators of humoral immunity.

Khan AR, Hams E, Floudas A, Sparwasser T, Weaver CT, Fallon PG.

Nat Commun. 2015 Jan 22;6:5997. doi: 10.1038/ncomms6997.

PMID:
25609381
10.

Antigen-specific B lymphocytes acquire proteoglycan aggrecan from cartilage extracellular matrix resulting in antigen presentation and CD4+ T-cell activation.

Ciechomska M, Wilson CL, Floudas A, Hui W, Rowan AD, van Eden W, Robinson JH, Knight AM.

Immunology. 2014 Jan;141(1):70-8. doi: 10.1111/imm.12169.

Supplemental Content

Loading ...
Support Center